# De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

Study · id `cardio:ct-nct05213676` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05213676](<https://clinicaltrials.gov/study/NCT05213676>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05213676

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 900 participants.

## Technical summary

Registry record NCT05213676. Randomized; no masking; primary purpose treatment. Start 2025-11-01 (actual); primary completion 2030-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 900 participants (planned count; ClinicalTrials.gov record NCT05213676, source copy `cardio:ctgov-nct05213676-2026-10-29`, retrieved 2026-10-31)
- Started: 2025-11-01 (actual) (ClinicalTrials.gov record NCT05213676, source copy `cardio:ctgov-nct05213676-2026-10-29`, retrieved 2026-10-31)
- Primary completion: 2030-10-31 (anticipated) (ClinicalTrials.gov record NCT05213676, source copy `cardio:ctgov-nct05213676-2026-10-29`, retrieved 2026-10-31)
- Completion: 2031-04-30 (anticipated) (ClinicalTrials.gov record NCT05213676, source copy `cardio:ctgov-nct05213676-2026-10-29`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT05213676, source copy `cardio:ctgov-nct05213676-2026-10-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05213676-2026-10-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
- Condition: Congenital Diaphragmatic Hernia
- Intervention (Drug): Inhaled Nitric Oxide (iNO) use
- Intervention (Other): De-implementation of Inhaled Nitric Oxide (iNO) use
- Lead sponsor: The University of Texas Health Science Center, Houston
- Lead sponsor class: OTHER
- Collaborator: University of Tennessee & LeBonheur Children's Hospital (UT-LBCH)
- Collaborator class: UNKNOWN
- Collaborator: Children's Hospital of Orange County
- Collaborator class: OTHER
- Collaborator: Medical University of South Carolina Children's Health (MUSC)
- Collaborator class: UNKNOWN
- Collaborator: University of Michigan & CS Mott Children's Hospital (UM-CSMott)
- Collaborator class: UNKNOWN
- Collaborator: Randall Children's Hospital-Portland (RCH)
- Collaborator class: UNKNOWN
- Collaborator: Stanford University & Lucile Packard Children's Hospital (Stanford-LPCH)
- Collaborator class: UNKNOWN
- Collaborator: Rady Children's Hospital, San Diego
- Collaborator class: OTHER
- Collaborator: Boston Children's Hospital
- Collaborator class: OTHER
- Collaborator: Indiana University & Riley Children's Hospital (IU-RiCH)
- Collaborator class: UNKNOWN
- Collaborator: Norton Children's Hospital
- Collaborator class: OTHER
- Collaborator: University of Utah & Primary Children's Hospital (Utah-PCH)
- Collaborator class: UNKNOWN
- Collaborator: University of Washington & Seattle Children's Hospital (UW-SCH)
- Collaborator class: UNKNOWN
- Collaborator: University of Alabama & Children's Hospital of Alabama (UAB-CoA)
- Collaborator class: UNKNOWN
- Collaborator: University of Arkansas
- Collaborator class: OTHER
- Collaborator: Vanderbilt University Medical Center
- Collaborator class: OTHER
- Collaborator: University of Southern California & Children's Hospital Los Angeles (USC-CHLA)
- Collaborator class: UNKNOWN
- Collaborator: Emory University & Children's Healthcare of Atlanta (CHOA)
- Collaborator class: UNKNOWN
- Collaborator: Children's Hospital Colorado
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)
- Registry lists this organization as the lead sponsor: The University of Texas Health Science Center, Houston (`cardio:org-the-university-of-texas-health-science-center-houston`)
- Registry lists this organization as a collaborator: Boston Children's Hospital (`cardio:org-boston-children-s-hospital`)
- Registry lists this organization as a collaborator: University of Arkansas (`cardio:org-university-of-arkansas`)
- Registry lists this organization as a collaborator: Vanderbilt University Medical Center (`cardio:org-vanderbilt-university-medical-center`)
- Registry lists this organization as a collaborator: Children's Hospital Colorado (`cardio:org-children-s-hospital-colorado`)

## Provenance

Content hash: fdb273ed80939522dce7bd95ef7dd40d905594b5804916bf1be42dde98f17c2b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
